Heart failure & cardiomyopathies

Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort

Circ Arrhythm ElectrophysiolPublished Cohort study

Authors' conclusion

Our main results suggest that the presence and extension of low QRS voltage can be a risk predictor for HF-death/HTx in ARVC patients, regardless of the arrhythmic risk.

Study context

Population
Patients with definite arrhythmogenic right ventricular cardiomyopathy (ARVC), Brazilian cohort
Participants
111 patients
Outcome
Life-threatening arrhythmic events (LTAE) and HF death or heart transplantation (HF-death/HTx)
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

5 years
5-year cumulative probability of LTAE
30%
5-year cumulative probability of heart failure (HF)-death/HTx
10%
Predictor of HF-death/HTx: reduced RV EF
HR 0.93; P=0.010
Predictor of HF-death/HTx: HF symptoms
HR 4.37; P=0.010
Predictor of HF-death/HTx: epsilon wave
HR 4.99; P=0.015
Predictor of HF-death/HTx: number of leads with low QRS voltage (28% higher risk per additional lead)
HR 1.28; P=0.001
Predictor of LTAE: prior syncope
HR 1.81; P=0.040
Predictor of LTAE: number of leads with T wave inversion
HR 1.17; P=0.039
Predictor of LTAE: low QRS voltage (17% higher risk per additional lead)
HR 1.12; P=0.021
Predictor of LTAE: younger age
HR 0.97; P=0.006
Predictor of LTAE: prior ventricular arrhythmia/VF
HR 2.45; P=0.012

Observational data: associations, not effects.

Further findings

HF-death/HTx in patients without ventricular arrhythmia before diagnosis (subgroup, n = 40)

Number of leads with low QRS voltage independently associated with HF-death/HTx
HR 1.68; P=0.023

Original publication

Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort. Circ Arrhythm Electrophysiol. Published 31 January 2023. doi:10.1161/circep.122.011391

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.